Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
📍 The outcome
{ "epilogue": "Eli Lilly expanded early and special access to its experimental, unapproved obesity drug retatrutide for certain patients. The program put physicians on the front line of next-generation GLP-1 demand as coverage highlighted both the access program and the drug's black market economy." }
Epilogue added 43d ago, after coverage quieted.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Where it stands
- Velocity & Diffusion: Coverage escalated across 9 distinct news outlets with 11 published articles, achieving a live velocity of 8.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Eli Lilly to allow more patients to apply for special access to unapproved obesity drug" developed substantial multi-source reporting across the Business sector, tracked across 9 distinct newsrooms by Newsylist.
Key reporting was led by Houston Chronicle, MDLinx, STAT and RAPS. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 43d ago.
Who reported it (11)
-
-
-
Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more STAT · 94d ago broke it first
-
-
-
Three biotechs with three news updates STAT · 94d ago broke it first
-
-
-
-
-
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug STAT · 94d ago broke it first
Answered
What drove coverage for Eli Lilly to allow more patients to apply for special access to unapproved ?
Coverage spiked when 9 independent newsrooms published 11 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.